{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:52:01Z","timestamp":1756385521916},"reference-count":27,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMIR"],"published-print":{"date-parts":[[2018,12,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Sarcoidosis is a multisystem granulomatous disorder of unknown origin\ncharacterized by nonspecific clinical symptomatology. 18F-FDG PET\/CT can visualize activated\ninflammatory cells of sarcoidosis and simultaneously provide whole-body images.\n&lt;\/P&gt;&lt;P&gt;\nObjective: To evaluate the clinical usefulness of 18F-FDG PET\/CT and its semiquantitative parameters\nfor the assessment of treatment efficacy in patients with sarcoidosis.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> Thirty-one consecutive patients who performed 18F-FDG PET\/CT for sarcoidosis assessment\nwere selected. All subjects performed 18F-FDG PET\/CT before any treatment (PET1) and\nafter 6-12 months (PET2). SUVmax and SUVmean on PET1 and PET2 were collected. SUVs values\nwere employed to evaluate the ratios with the liver (R-LIVERmax, R-LIVERmean) and the\nblood (R-BLOODmax, R-BLOODmean). The difference between the PET1 and PET2 values was\nevaluated (&amp;#916;SUVmax, &amp;#916;SUVmean, &amp;#916;R-LIVERmax, &amp;#916;R-LIVERmean, &amp;#916;R-BLOODmax, &amp;#916;R-BLOODmean).\nPatients were classified as Responders (R), Partial-Responders (PR) and Non-\nResponders (NR).\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results: <\/jats:title>\n<jats:p>Seventeen patients (54.8%) had a complete metabolic response (R), 4 (12.9%) were PR\nwhile 10 (32.3%) had no Metabolic Response (NR). The chi-square test showed that response\ngroups were related neither to the stage of disease (p=0.59) nor to therapy performed (p&lt;0.079).\nThe comparison between each &amp;#916; semiquantitative parameter showed a statistically significant decrease\nfrom PET1 to PET2 (0.0001 &lt; p &lt; 0.002). The comparison between &amp;#916; mean values in relation\nto response groups showed to be statistically significant (0.001 &lt; p &lt; 0.005). Conversely, they did not\nshow statistical significance in relation to the clinical stage groups and to the kind of therapy performed\n(p&gt;0.05). Pearson\u2019s coefficient demonstrated a reverse correlation between a number of\nsites still involved in disease after therapy and each &amp;#916; semiquantitative parameters (p&amp;#8804;0.0001).\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion: <\/jats:title>\n<jats:p> 18F-FDG PET\/CT should be considered a useful technique for the evaluation of sarcoidosis\nand semiquantitative parameters. Further studies are needed to determine the long-term\nimpact of 18F-FDG PET\/CT on clinical outcomes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573405614666180522075828","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T07:09:46Z","timestamp":1526972986000},"page":"32-38","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Performance of <sup>18<\/sup>F-FDG PET\/CT Semiquantitative Analysis in the Management of Sarcoidosis"],"prefix":"10.2174","volume":"15","author":[{"given":"Giuseppe","family":"Rubini","sequence":"first","affiliation":[{"name":"Nuclear Medicine Unit, DIM, University of Bari \u201cAldo Moro\u201d, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, DIM, University of Bari \u201cAldo Moro\u201d, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna","family":"Altini","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, DIM, University of Bari \u201cAldo Moro\u201d, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Cimino","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, DIM, University of Bari \u201cAldo Moro\u201d, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Fanelli","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, DIM, University of Bari \u201cAldo Moro\u201d, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artor","family":"Niccoli Asabella","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, DIM, University of Bari \u201cAldo Moro\u201d, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"149","volume":"16","author":"Hunninghake G.W.","year":"1999","unstructured":"Hunninghake GW, Costabel U, Ando M. Sarcoidosis Vasc Diffuse Lung Dis, ATS\/ERS\/WASOG statement on sarcoidosis.,, 1999, 16,, 149-173,","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"Iannuzzi M.C.","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS. N Engl J Med, Sarcoidosis.,, 2007, 357,, 2153-2165,","journal-title":"N Engl J Med"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2967\/jnumed.112.104380","volume":"53","author":"Sobic-Saranovic D.","year":"2012","unstructured":"Sobic-Saranovic D, Grozdic I, Videnovic-Ivanov J. J Nucl Med, The Utility of 18F-FDG PET\/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.,, 2012, 53,, 1-7,","journal-title":"J Nucl Med"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00259-008-0770-9","volume":"35","author":"Braun J.J.","year":"2008","unstructured":"Braun JJ, Kessler R, Constantinesco A. Eur J Nucl Med Mol Imaging, 18F-FDG PET\/CT in sarcoidosis management: Review and report of 20 cases.,, 2008, 35,, 1537-1543,","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.rmed.2012.01.013","volume":"106","author":"Judson M.A.","year":"2012","unstructured":"Judson MA. Respir Med, The treatment of pulmonary sarcoidosis.,, 2012, 106,, 1351-1361,","journal-title":"Respir Med"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(03)12888-7","volume":"361","author":"Baughman R.P.","year":"2003","unstructured":"Baughman RP, Lower EE, du Bois RM. Lancet, Sarcoidosis.,, 2003, 361,, 1111-1118,","journal-title":"Lancet"},{"key":"ref=7","first-page":"372","volume":"33","author":"Maturu V.N.","year":"2016","unstructured":"Maturu VN, Rayamajhi SJ, Agarwal R. Sarcoidosis Vasc Diffuse Lung Dis, Role of serial F-18 FDG PET\/CT scans in assessing treatment response and predicting relapses in patients with symptomatic sarcoidosis.,, 2016, 33,, 372-380,","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1378\/chest.07-1178","volume":"132","author":"Teirstein A.S.","year":"2007","unstructured":"Teirstein AS, Machac J, Almeida O. Chest, Results of 188 whole-body FDG PET scans in 137 patients with sarcoidosis.,, 2007, 132,, 1949-1953,","journal-title":"Chest"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"e864","DOI":"10.1097\/MD.0000000000000864","volume":"94","author":"Altini C.","year":"2015","unstructured":"Altini C, Niccoli AA, Di Palo A. Medicine (Baltimore), 18F-FDG PET\/CT role in staging of gastric carcinomas: Comparison with conventional contrast enhancement computed tomography.,, 2015, 94,, e864-,","journal-title":"Medicine (Baltimore)"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00261-014-0277-8","volume":"40","author":"Altini C.","year":"2015","unstructured":"Altini C, Niccoli AA, De Luca R. Abdom Imaging, Comparison of (18)F-FDG PET\/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer.,, 2015, 40,, 1190-1202,","journal-title":"Abdom Imaging"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12149-014-0850-9","volume":"28","author":"Niccoli Asabella A.","year":"2014","unstructured":"Niccoli Asabella A, Ciccone MM, Cortese F. Ann Nucl Med, Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: A pilot study.,, 2014, 28,, 571-579,","journal-title":"Ann Nucl Med"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-2007-970332","volume":"28","author":"Rosen Y.","year":"2007","unstructured":"Rosen Y. Semin Respir Crit Care Med, Pathology of sarcoidosis.,, 2007, 28,, 36-52,","journal-title":"Semin Respir Crit Care Med"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1183\/09031936.00088612","volume":"41","author":"Keijsers R.G.M.","year":"2013","unstructured":"Keijsers RGM, van den Heuvel DAF, Grutters JC. Eur Respir J, Imaging the inflammatory activity of sarcoidosis.,, 2013, 41,, 743-751,","journal-title":"Eur Respir J"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.rlu.0000252216.68848.d7","volume":"32","author":"Kaira K.","year":"2007","unstructured":"Kaira K, Ishizuka T, Yanagitani N. Clin Nucl Med, Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis.,, 2007, 32,, 114-116,","journal-title":"Clin Nucl Med"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.rlu.0000249627.05003.ac","volume":"32","author":"Nguyen B.D.","year":"2007","unstructured":"Nguyen BD. Clin Nucl Med, F-18 FDG PET imaging of disseminated sarcoidosis.,, 2007, 32,, 53-54,","journal-title":"Clin Nucl Med"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.crad.2011.04.018","volume":"67","author":"Vardhanabhuti V.","year":"2012","unstructured":"Vardhanabhuti V, Venkatanarasimha N, Bhathagar G. Clin Radiol, Extrapulmonary manifestation of sarcoidosis.,, 2012, 67,, 263-276,","journal-title":"Clin Radiol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/RLU.0b013e31828731f5","volume":"38","author":"Sobic-Saranovic D.P.","year":"2013","unstructured":"Sobic-Saranovic DP, Grozdic IT, Videnovic-Ivanov J. Clin Nucl Med, Responsiveness of FDG PET\/CT to treatment of patients with active chronic sarcoidosis.,, 2013, 38,, 516-521,","journal-title":"Clin Nucl Med"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000204901","volume":"79","author":"De Prost N.","year":"2010","unstructured":"De Prost N, Kerrou K, Sibony M. Respiration, Fluorine-18 fluorodeoxyglucose with positron emission tomography revealed bonemarrow involvement in sarcoidosis patients with anaemia.,, 2010, 79,, 25-31,","journal-title":"Respiration"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2214\/ajr.182.4.1820975","volume":"182","author":"Aberg C.","year":"2004","unstructured":"Aberg C, Ponzo F, Raphael B. AJR, FDG positron emission tomography of bone involvement in sarcoidosis.,, 2004, 182,, 975-977,","journal-title":"AJR"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/RLU.0b013e318219b28b","volume":"36","author":"Asabella A.N.","year":"2011","unstructured":"Asabella AN, Gatti P, Notaristefano A. Clin Nucl Med, F-18 FDG PET\/CT in the diagnosis of a rare case of neurosarcoidosis in a patient with diabetes insipidus.,, 2011, 36,, 795-797,","journal-title":"Clin Nucl Med"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11547-013-0306-7","volume":"119","author":"Rubini G.","year":"2014","unstructured":"Rubini G, Cappabianca S, Altini C. Radiol Med, Current clinical use of 18FDG-PET\/CT in patients with thoracic and systemic sarcoidosis.,, 2014, 119,, 64-74,","journal-title":"Radiol Med"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1183\/09031936.94.07030624","volume":"7","year":"1994","unstructured":". Eur Respir J, Activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11 1993.,Consensus conference, 1994, 7,, 624-627,","journal-title":"Eur Respir J"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/RLU.0b013e31827a27df","volume":"38","author":"Ambrosini V.","year":"2013","unstructured":"Ambrosini V, Zompatori M, Fasano L. Clin Nucl Med, 18F-FDG PET\/CT for the assessment of disease extension and activity in patients with sarcoidosis. Results of preliminary prospective study.,, 2013, 38,, 171-177,","journal-title":"Clin Nucl Med"},{"key":"ref=24","first-page":"177","volume":"57","author":"Imperiale A.","year":"2013","unstructured":"Imperiale A, Riehm S, Braun JJ. Q J Nucl Med Mol Imaging, Interest of [18F] FDG PET\/CT for treatment efficacy assessment inaggressive phenotype of sarcoidosis with special emphasis on sinonasal involvement.,, 2013, 57,, 177-186,","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/snuc.2002.127291","volume":"32","author":"Alavi A.","year":"2002","unstructured":"Alavi A, Gupta N, Alberini JL. Semin Nucl Med, Positron emission tomography imaging in nonmalignant thoracic disorders.,, 2002, 32,, 293-321,","journal-title":"Semin Nucl Med"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00508-014-0647-9","volume":"127","author":"Yakar A","year":"2015","unstructured":"Yakar A, Yakar F. Wien Klin Wochenschr, Sezar m, et al Use of PET-CT for the assessment of treatment results in patients with sarcoidosis.,, 2015, 127,, 274-282,","journal-title":"Wien Klin Wochenschr"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1440-1843.2011.01966.x","volume":"16","author":"Umeda Y.","year":"2011","unstructured":"Umeda Y, Demura Y, Morikawa M. Respirology, Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis.,, 2011, 16,, 713-720,","journal-title":"Respirology"}],"container-title":["Current Medical Imaging Formerly Current Medical Imaging Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/162315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T20:04:18Z","timestamp":1573675458000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/162315\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573405614666180522075828","relation":{},"ISSN":["1573-4056"],"issn-type":[{"value":"1573-4056","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}